PuSH - Publikationsserver des Helmholtz Zentrums München

Huan, T.* ; Esko, T.* ; Peters, M.J.* ; Pilling, L.C.* ; Schramm, K. ; Schurmann, C.* ; Chen, B.H.* ; Liu, C.* ; Joehanes, R.* ; Johnson, A.D.* ; Yao, C.* ; Ying, S.X.* ; Courchesne, P.* ; Milani, L.* ; Raghavachari, N.* ; Wang, R.* ; Liu, P.* ; Reinmaa, E.* ; Dehghan, A.* ; Hofman, A.* ; Uitterlinden, A.G.* ; Hernandez, D.G.* ; Bandinelli, S.* ; Singleton, A.* ; Melzer, D.* ; Metspalu, A.* ; Carstensen, M.* ; Grallert, H. ; Herder, C.* ; Meitinger, T. ; Peters, A. ; Roden, M.* ; Waldenberger, M. ; Dörr, M.* ; Felix, S.B.* ; Zeller, T.* ; ICBP Consortium (Levy, D.*) ; Vasan, R.S.* ; O'Donnell, C.J.* ; Munson, P.J.* ; Yang, X.* ; Prokisch, H. ; Völker, U.* ; van Meurs, J.B.* ; Ferrucci, L.*

A meta-analysis of gene expression signatures of blood pressure and hypertension.

PLoS Genet. 11:e1005035 (2015)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Genome-wide association studies (GWAS) have uncovered numerous genetic variants (SNPs) that are associated with blood pressure (BP). Genetic variants may lead to BP changes by acting on intermediate molecular phenotypes such as coded protein sequence or gene expression, which in turn affect BP variability. Therefore, characterizing genes whose expression is associated with BP may reveal cellular processes involved in BP regulation and uncover how transcripts mediate genetic and environmental effects on BP variability. A meta-analysis of results from six studies of global gene expression profiles of BP and hypertension in whole blood was performed in 7017 individuals who were not receiving antihypertensive drug treatment. We identified 34 genes that were differentially expressed in relation to BP (Bonferroni-corrected p<0.05). Among these genes, FOS and PTGS2 have been previously reported to be involved in BP-related processes; the others are novel. The top BP signature genes in aggregate explain 5%-9% of inter-individual variance in BP. Of note, rs3184504 in SH2B3, which was also reported in GWAS to be associated with BP, was found to be a trans regulator of the expression of 6 of the transcripts we found to be associated with BP (FOS, MYADM, PP1R15A, TAGAP, S100A10, and FGBP2). Gene set enrichment analysis suggested that the BP-related global gene expression changes include genes involved in inflammatory response and apoptosis pathways. Our study provides new insights into molecular mechanisms underlying BP regulation, and suggests novel transcriptomic markers for the treatment and prevention of hypertension.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
7.528
1.709
81
86
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Genome-wide Association; Peripheral-blood; Microarray Analysis; Potassium; Cells; Prevention; Profile; Sodium; Trials; Mice
Sprache englisch
Veröffentlichungsjahr 2015
HGF-Berichtsjahr 2015
ISSN (print) / ISBN 1553-7390
e-ISSN 1553-7404
Zeitschrift PLoS Genetics
Quellenangaben Band: 11, Heft: 3, Seiten: , Artikelnummer: e1005035 Supplement: ,
Verlag Public Library of Science (PLoS)
Verlagsort San Francisco
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Human Genetics (IHG)
Institute of Epidemiology (EPI)
POF Topic(s) 90000 - German Center for Diabetes Research
30202 - Environmental Health
30501 - Systemic Analysis of Genetic and Environmental Factors that Impact Health
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-501900-071
G-504091-002
G-504091-001
G-500700-001
G-504000-001
G-501900-401
G-501900-402
PubMed ID 25785607
Scopus ID 84989801107
Erfassungsdatum 2015-03-20